Yitong Technology(SZ:300211) Mei Ri Jing Ji Xin Wen·2025-10-23 16:11Group 1 - The core point of the article is that *ST Yitong (SZ 300211) announced the convening of its 20th meeting of the 8th board of directors on October 23, 2025, to review the full text of the Q3 2025 report and other documents [1] - For the year 2024, the revenue composition of *ST Yitong is entirely from the manufacturing of computers, communications, and other electronic equipment, accounting for 100.0% [1] - As of the time of reporting, *ST Yitong has a market capitalization of 3.1 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing challenges in fundraising [1]